Sunday, May 19, 2013 Last update: 3:34 AM
Company Tech News as it Breaks

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

print this article - email to a friend - join our eNewsletter
Submitted by admin on 2/8/2013 @ 3:45 PM
Companies mentioned in this article: Array BioPharma Inc.

BOULDER, Colo., Feb. 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) 

    Event:     Leerink Swann Healthcare Conference
    Presenter: Ron Squarer, Chief Executive Officer
    Date:      Thursday, February 14, 2013
    Time:      8:00 a.m. Eastern Time
    Location:  The Waldorf Astoria, New York, NY
    Webcast:   www.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. During 2013, Array expects to make substantial progress in generating data to inform registration study decisions for our wholly-owned hematology programs, ARRY-520 and ARRY-614. Array-invented MEK162 will be tested in a Phase 3 trial in NRAS melanoma which is scheduled to start in April 2013, as well as BRAF mutant melanoma later in 2013 (with Novartis). Also, AstraZeneca recently announced a potential start of a Phase 3 trial with Array-invented selumetinib in non-small cell lung cancer during the second half of 2013. For more information on Array, please go to www.arraybiopharma.com.

    CONTACT:                        Tricia Haugeto
                                    Array BioPharma Inc.
                                    303-386-1193
                                    thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.